iTC200 MicroCalorimetry Cell Control Unit
iTC200 微量热池控制单元
基本信息
- 批准号:8639053
- 负责人:
- 金额:$ 9.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAnthrax diseaseAreaBiochemistryBiological ProcessBiomedical ResearchBiophysicsCellsChemistryCitiesDiseaseDissociationDrug TargetingEquipmentFundingGrantHIVHeart failureHydrogen BondingInstitutesKnowledgeLigandsMale Contraceptive AgentsMalignant NeoplasmsMinnesotaMolecular BiologyPharmaceutical ChemistryRelative (related person)ResearchResearch PersonnelTherapeuticThermodynamicsTitrationsTrainingTuberculosisTwin Multiple BirthUnited States National Institutes of HealthUniversitiescarcinogenesisdesigndrug discoveryenthalpyinhibitor/antagonistinstrumentmicrocalorimetryreceptorsmall molecule
项目摘要
DESCRIPTION (provided by applicant): This equipment grant is requesting funds for the purchase of an isothermal titration microcalorimeter (ITC) for the determination of ligand receptor dissociation constants and thermodynamic parameters by a group of very productive NIH-funded researchers in chemistry, medicinal chemistry, biochemistry, molecular biology, and biophysics. These investigators are involved in NIH funded research that deals either with the design and synthesis of small molecules for potential drug targets or the utilization of small molecule ligands to study biological processes associated with various diseases. Their research addresses such diverse areas as male contraceptives, tuberculosis, anthrax, heart failure, cancer, carcinogenesis, and HIV. Presently, there is no available ITC instrument at the University of Minnesota-Twin Cities campus, which is a leader nationally in biomedical research. Many inhibitors derive their affinity by non- specific entropic interactions (i.e. desolvation) rater than specific hydrogen-bonding and van der Waal interactions that is manifested in the enthalpy. Thus, knowledge of the relative thermodynamic signature is vitally important. The Institute of Therapeutics and Drug Discovery (ITDD) will maintain the instrument and provide user training of the ITC, which will be paid for by the Department of Medicinal Chemistry.
描述(由申请人提供):该设备补助金要求资金购买等温滴定微量热仪(ITC),用于测定配体受体解离常数和热力学参数,由NIH资助的化学,药物化学,生物化学,分子生物学和生物物理学研究人员组成。这些研究人员参与了NIH资助的研究,这些研究涉及潜在药物靶点的小分子的设计和合成,或利用小分子配体研究与各种疾病相关的生物学过程。他们的研究涉及男性避孕药、肺结核、炭疽、心力衰竭、癌症、致癌作用和艾滋病毒等不同领域。目前,明尼苏达大学双城校区没有ITC仪器,该校区在生物医学研究方面处于全国领先地位。许多抑制剂通过非特异性熵相互作用(即去溶剂化)获得其亲和力,而非特异性氢键和货车范德华相互作用(表现为焓)。因此,了解相关的热力学特征是至关重要的。治疗和药物发现研究所(ITDD)将维护仪器并提供ITC的用户培训,费用由药物化学系支付。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Multiplex surface-enhanced Raman scattering detection of deoxynivalenol and ochratoxin A with a linear polymer affinity agent.
- DOI:10.1039/d0ma00608d
- 发表时间:2020-12-01
- 期刊:
- 影响因子:5
- 作者:Rodriguez RS;Szlag VM;Reineke TM;Haynes CL
- 通讯作者:Haynes CL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Courtney C Aldrich其他文献
Going Viral.
病毒式传播。
- DOI:
10.1021/acsinfecdis.5b00098 - 发表时间:
2015 - 期刊:
- 影响因子:5.3
- 作者:
Kristen N Kindrachuk;Courtney C Aldrich - 通讯作者:
Courtney C Aldrich
Antimetabolite poisoning of cofactor biosynthesis.
辅因子生物合成的抗代谢物中毒。
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Leonardo K Martinelli;Courtney C Aldrich - 通讯作者:
Courtney C Aldrich
Courtney C Aldrich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Courtney C Aldrich', 18)}}的其他基金
Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease
优化利福霉素以克服非结核分枝杆菌的内在耐药性,改善 NTM 肺病的治疗
- 批准号:
10713137 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Overcoming Pyrazinamide Resistance with Pyrazinoate-Cephalosporin Conjugates
用吡嗪酸-头孢菌素缀合物克服吡嗪酰胺耐药性
- 批准号:
10088387 - 财政年份:2020
- 资助金额:
$ 9.36万 - 项目类别:
Overcoming Pyrazinamide Resistance with Pyrazinoate-Cephalosporin Conjugates
用吡嗪酸-头孢菌素缀合物克服吡嗪酰胺耐药性
- 批准号:
9895968 - 财政年份:2020
- 资助金额:
$ 9.36万 - 项目类别:
Targeting Biotin Metabolism in Mycobacterium Tuberculosis
靶向结核分枝杆菌中的生物素代谢
- 批准号:
10322125 - 财政年份:2019
- 资助金额:
$ 9.36万 - 项目类别:
Targeting Biotin Metabolism in Mycobacterium Tuberculosis
靶向结核分枝杆菌中的生物素代谢
- 批准号:
10543561 - 财政年份:2019
- 资助金额:
$ 9.36万 - 项目类别:
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis
阻断分枝杆菌素生物合成的结核病铁载体抑制剂
- 批准号:
9890916 - 财政年份:2018
- 资助金额:
$ 9.36万 - 项目类别:
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis
阻断分枝杆菌素生物合成的结核病铁载体抑制剂
- 批准号:
10368998 - 财政年份:2018
- 资助金额:
$ 9.36万 - 项目类别:
2017 Tuberculosis Drug Discovery and Development Gordon Research Conference and Gordon Research Seminar
2017结核病药物发现与开发戈登研究大会暨戈登研究研讨会
- 批准号:
9330545 - 财政年份:2017
- 资助金额:
$ 9.36万 - 项目类别:
A fluorescence displacement assay for BioA: An enzyme involved in biotin biosynth
BioA 的荧光置换测定:一种参与生物素生物合成的酶
- 批准号:
8262096 - 财政年份:2012
- 资助金额:
$ 9.36万 - 项目类别:
A Fluorescence Displacement Assay for the Biotin Biosynthetic Enzyme BioA
生物素生物合成酶 BioA 的荧光置换测定
- 批准号:
8403185 - 财政年份:2012
- 资助金额:
$ 9.36万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 9.36万 - 项目类别:
Continuing Grant